Bio-Techne Corporation (NASDAQ: TECH ) is the market leader in high-quality biological reagents used in the life science market, manufacturing high-quality proteins, antibodies and immunoassays. I think the company will benefit from the long-term growth in cellAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am ...

Hong Kong, July 24, 2025 (GLOBE NEWSWIRE) -- Cre8 Enterprise Limited (Nasdaq: CRE) (the “Company”), a Hong Kong-based integrated financial printing service provider, today announced the closing of its initial public offering (the “Offering”) of 1,450,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a price of $4.00 per share (the “Offering Price”). The Class A Ordinary Shares commenced trading on the Nasdaq Capital Market on July 23, 2025 under the ticker symbol “CRE.” The Company received gro ...

Core Insights - Value investing focuses on identifying stocks trading below their intrinsic value, allowing investors to benefit as market prices align with true company value over time [1] - Earnings yield, calculated as earnings per share divided by stock price, is a useful metric for identifying undervalued stocks, with a higher yield indicating potential undervaluation [2][4] - A screening criterion of an earnings yield greater than 10% is established, alongside other parameters like estimated EPS growth and average daily volume [6][7] Company Highlights - IAMGOLD Corporation (IAG) is a gold exploration and mining company with projected earnings growth of 44% and 40% for 2025 and 2026, respectively, and currently holds a Zacks Rank 1 [9] - Plains GP Holdings (PAGP) is involved in crude oil and refined products transportation, with earnings growth estimates of 206% and 24% for 2025 and 2026, respectively, also holding a Zacks Rank 1 [10][11] - Hope Bancorp (HOPE) provides commercial banking services, with earnings growth estimates of 12% and 40% for 2025 and 2026, and holds a Zacks Rank 1 [12] - CommScope Holding Company, Inc. (COMM) offers communication network infrastructure solutions, with an extraordinary earnings growth estimate of 3,167% for 2025 and 28% for 2026, holding a Zacks Rank 2 [13] - Harmony Biosciences Holdings Inc. (HRMY) focuses on therapies for rare neurological disorders, with earnings growth estimates of 22% and 32% for 2025 and 2026, and holds a Zacks Rank 2 [14]

Core Viewpoint - The First Meteorological and Economic Expo showcased the integration of meteorology into various industries, highlighting its role as a key driver for technological advancement and economic growth [2][4][8]. Group 1: Expo Overview - The Expo was held from July 18 to 20, 2025, at the Hefei Binhu International Convention and Exhibition Center, organized by the China Meteorological Service Association [1]. - The theme of the Expo was "Integrating Meteorology into the New Economy, Joining Hands to Create a Better Future," presenting a comprehensive landscape of the meteorological economy for the first time [2]. Group 2: Exhibitors and Technologies - Over a hundred exhibitors from more than 20 fields, including meteorology, artificial intelligence, low-altitude economy, transportation, tourism, healthcare, and financial insurance, participated in the Expo [3]. - Innovative meteorological technology products were showcased, such as intelligent integrated drones, laser virtual wind towers, and air cannons for smog dispersal and hail suppression [3][7]. Group 3: Industrial Connections - The Expo facilitated connections among industrial, capital, and innovation chains, creating a full-lifecycle industrial service system through investment introductions, industrial matchmaking, and technology pairing [4]. - Exhibiting enterprises achieved precise connections and efficient transformations through product displays and supply-demand matchmaking [4]. Group 4: Advancements in Meteorological Services - High-tech meteorological products, including cloud-penetrating detection drones and pocket-sized weather stations, were introduced, shifting reliance from reactive to proactive meteorological services [7]. - The Expo served as a crucial hub for advancing the meteorological economy from concept to practice, emphasizing the integration of meteorology into everyday life [8]. Group 5: Educational and Scientific Exchange - The Expo featured a dedicated zone for university scientific exchange and introduced investment and financing institutions, pooling innovative resources to support enterprise innovation and industrial development [12]. - Popular science initiatives were highlighted, making meteorological knowledge accessible through interactive experiences and educational resources [11]. Group 6: Participation and Future Outlook - Nearly 2,000 participants, including government representatives, international organizations, and industry professionals, attended the Expo, marking a significant moment in the development of the meteorological economy [14]. - The China Meteorological Service Association celebrated its 10th anniversary during the Expo and aims to continue driving innovation and cooperation in the meteorological economy [15].

Core Viewpoint - Tevogen Bio Holdings Inc. has announced the publication of its international patent application for a machine learning-based technology aimed at identifying immunologically active peptides, which is crucial for developing targeted therapies for diseases like cancer and infections [1][2]. Group 1: Technology and Innovation - The patented technology utilizes machine learning algorithms, developed in collaboration with Microsoft and Databricks, to enhance the identification of peptides that interact strongly with the immune system [1]. - Traditional methods for identifying these peptides often overlook important genetic diversity factors, but Tevogen.AI's approach aims to address these limitations [2]. - The technology focuses on efficiently screening and ranking potential peptides based on their immunological activity and continuously refining predictions using real-world data [6]. Group 2: Strategic Goals - The company emphasizes the importance of leveraging artificial intelligence to accelerate discovery, shorten development timelines, and reduce costs in the context of personalized T cell therapies [2]. - The goal is to deliver commercially attractive and economically viable therapies for various diseases, including cancers and infectious diseases [2].

Group 1 - Viewbix Inc. has closed a private placement for approximately $4.5 million, involving strategic institutional investors [1] - The company completed an uplisting of its shares on the Nasdaq Capital Market on June 5, 2025 [1] - Following the transaction, Viewbix plans to explore new business opportunities and investments in various sectors [2] Group 2 - Viewbix operates in digital advertising through subsidiaries Gix Media Ltd. and Cortex Media Group Ltd., focusing on search and digital content [3] - The search segment develops software solutions for automation, optimization, and monetization of internet campaigns [3] - The digital content segment creates and edits content in multiple languages to generate revenue from major advertising platforms like Google, Facebook, Yahoo, and Apple [3] - Viewbix's technological tools enhance earnings for advertisers and website owners from their advertising campaigns [3]

Core Viewpoint - Lavoro Limited has received a notice of non-compliance from Nasdaq due to the delayed filing of its interim financial information for the six-month period ended December 31, 2024 [1][2]. Group 1: Compliance and Regulatory Actions - The notice indicates that Lavoro is not in compliance with Nasdaq Listing Rule 5250(c)(2) [1]. - The company must submit a plan by September 8, 2025, to address how it intends to regain compliance with Nasdaq's listing rules [3]. - If the plan is accepted, Nasdaq may grant an exception of up to 180 calendar days, allowing compliance to be regained by December 29, 2025 [3][4]. Group 2: Company Background - Lavoro is Brazil's largest agricultural inputs retailer and a leading producer of agricultural biological products [5]. - The company operates across Latin America, including Brazil, Colombia, Uruguay, and Ecuador, and was founded in 2017 [5]. - Lavoro empowers small and medium-sized farmers to adopt emerging agricultural technologies to enhance productivity [5].

Core Viewpoint - Viewbix Inc. has successfully closed a private placement transaction, raising approximately $4.5 million through the sale of common stock and warrants, aimed at exploring new business opportunities and investments in various sectors [1][2][4]. Group 1: Private Placement Details - The private placement involved the issuance of approximately 925,923 units, with common units priced at $4.86 each and pre-funded units sold at a similar price minus a minimal exercise price [3]. - Each unit consists of one share of common stock and one common warrant, with an exercise price of $4.74 per share, and the common warrants have a term of 5.5 years [3]. - The closing of the private placement occurred on July 14, 2025, with gross proceeds of around $4.5 million before fees and expenses [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general corporate purposes and working capital, in conjunction with existing cash [4]. Group 3: Company Overview - Viewbix operates in the digital advertising sector through subsidiaries Gix Media Ltd. and Cortex Media Group Ltd., focusing on search technology and digital content creation [7]. - The company develops software solutions for automating and optimizing internet campaigns, aiming to enhance revenue generation for advertisers [7].

Core Insights - Quantum computers have the potential to revolutionize industries by performing complex calculations much faster than current supercomputers [1] - D-Wave Quantum and IonQ are two companies in the quantum computing sector that present intriguing investment opportunities, but their performance and strategies differ significantly [2] D-Wave Quantum - D-Wave's stock has increased over 90% in 2025, reaching a 52-week high of $19.77 in May, driven by a 509% year-over-year increase in Q1 revenue to $15 million, surpassing its total sales of $8.8 million for all of 2024 [4][5] - The revenue surge was attributed to the first sale of its proprietary Advantage quantum machine, shifting from a previous reliance on quantum computing as a service (QCaaS) [5] - D-Wave's Q1 operating loss improved to $11.3 million from $17.5 million in 2024, with total assets of $325.6 million, including $304.3 million in cash, and liabilities of $118.2 million [6] - The company has sufficient cash reserves, approximately $815 million after an equity offering, to sustain operations until profitability, with some funds allocated for acquisitions [7] IonQ - IonQ's stock performance has been less impressive, with a 9% increase through July 9, attributed to disappointing Q1 results [8] - Q1 revenue was flat at $7.6 million compared to 2024, while operating losses increased to $75.7 million from $52.9 million the previous year [9] - IonQ maintains a strong balance sheet with total Q1 assets of $850.1 million and liabilities of $85 million, and announced a $1 billion equity offering to bolster finances [10] - The company is focused on building a quantum computing network, which is costly and requires acquiring various capabilities, such as the recent acquisition of Lightsynq Technologies [11] Comparative Analysis - D-Wave claims to be the sole provider of both quantum gate technology and quantum annealing, while IonQ is pursuing a network-building strategy [12] - The long-term success of either company remains uncertain, with potential competition from larger players like Microsoft [13] - D-Wave's impressive Q1 results may not be sustainable, as they represent a shift from its traditional revenue model [14] - IonQ, despite a slow start in 2025, reported a 95% year-over-year revenue growth to $43.1 million by the end of 2024 and projects sales between $75 million and $95 million for 2025 [15] - Valuation metrics indicate that both D-Wave and IonQ have higher price-to-sales (P/S) ratios compared to Microsoft, suggesting potential overvaluation [16] Investment Strategy - Given the high valuations and uncertainty in the quantum computing sector, it may be prudent to wait for Q2 earnings reports to assess the sustainability of D-Wave's Q1 results and IonQ's recovery potential [18]

Core Viewpoint - Viewbix Inc. has entered into agreements for the sale of approximately $4.5 million shares of common stock and pre-funded warrants, aiming to explore new business opportunities and investments in various sectors [1][2][4]. Group 1: Transaction Details - The company will issue a total of 925,923 units, with common units priced at $4.86 each and pre-funded units priced similarly, minus a pre-funded warrant exercise price of $0.0001 [3]. - Each unit consists of one share of common stock and one common warrant, with an exercise price of $4.74 per share, valid for 5.5 years from issuance [3]. - The closing of the private placement is expected around July 14, 2025, pending customary closing conditions, with gross proceeds anticipated to be approximately $4.5 million before fees and expenses [4]. Group 2: Use of Proceeds - The net proceeds from the offering, along with existing cash, will be utilized for general corporate purposes and working capital [4]. Group 3: Company Overview - Viewbix operates in digital advertising through subsidiaries Gix Media Ltd. and Cortex Media Group Ltd., focusing on search and digital content [7]. - The search segment develops software solutions for automating, optimizing, and monetizing internet campaigns, while the digital content segment creates and edits content for various target audiences to generate revenue from major advertising platforms [7].